Colin Walsh

Director/Board Member at Korro Bio, Inc.

38 year

Health Technology

Finance

Consumer Services

Profile

Colin Walsh is currently a Director at Ceptur Therapeutics, Inc. He is also a Board Member at Element Science, Inc., a Partner at Qiming US Ventures Management, LLC, and a Board Member at Korro Bio, Inc. (Old).
Previously, he served as an Independent Director at Elevation Oncology, Inc. from 2019 to 2023 and as a Vice President at NanoDimension, Inc. Dr. Walsh holds a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of Massachusetts Amherst.

Colin Walsh active positions

Companies	Position	Start
Qiming US Ventures Management, LLC Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts.	Private Equity Investor	01/04/2019
Ceptur Therapeutics, Inc. Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation.	Director/Board Member	-
Korro Bio, Inc. Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.	Director/Board Member	01/08/2020
Element Science, Inc. Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA.	Director/Board Member	01/08/2019

All active positions of Colin Walsh

Former positions of Colin Walsh

Companies	Position	End
ELEVATION ONCOLOGY, INC.	Director/Board Member	21/09/2023
NanoDimension, Inc.	Corporate Officer/Principal	-

See the detail of Colin Walsh's experience

Training of Colin Walsh

University of California, Berkeley	Doctorate Degree
University of Massachusetts Amherst	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Colin Walsh's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ELEVATION ONCOLOGY, INC.	Health Technology

Private companies	5
Element Science, Inc. Element Science, Inc. Electronic Equipment/InstrumentsElectronic Technology Element Science, Inc. operates as a medical device and digital health company. It develops a wearable platform solution with proprietary technology in wearable patches, electrical design, machine learning algorithms and digital solutions. The company was founded by Uday N. Kumar in 2011 and is headquartered in San Francisco, CA.	Electronic Technology
Qiming US Ventures Management, LLC Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts.	Finance
Korro Bio, Inc. Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA.	Health Technology
Ceptur Therapeutics, Inc. Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation.	Health Technology
NanoDimension, Inc.	Finance

See company connections